FOLEY & LARDNER LLP

Lobbying for PAR HEALTH USA, LLC · Pharmaceutical and Medicine Manufacturing

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Pennsylvania · House · Senate · $70,000.00 income · posted Jul 19, 2026

Lobbying activity 2

Health Issues

Issues related to domestic pharmaceutical manufacturing; issues related to supply chain resilience.

Trade (domestic/foreign)

Issues related to pharmaceutical tariffs

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.